We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
351
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.5M | 0.05% |
44,342
+4,050
| +10% | +$363K |
|
352
American Homes 4 Rent
AMH
$12.1B
| $5.46M | 0.05% |
208,379
-49,290
| -19% | -$1.29M |
|
353
Aramark
ARMK
$15.1B
| $5.43M | 0.05% |
+173,376
| New | +$5.44M |
|
354
Cytokinetics
CYTK
$11B
| $5.43M | 0.05% |
+511,730
| New | +$5.26M |
|
|
CPLG
355
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $5.4M | 0.05% |
505,987
+123,672
| +32% | +$1.25M |
|
356
Churchill Downs
CHDN
$6.18B
| $5.33M | 0.05% |
77,750
-70,592
| -48% | -$4.6M |
|
357
Comfort Systems
FIX
$58.5B
| $5.32M | 0.05% |
106,744
-14,715
| -12% | -$715K |
|
358
Enanta Pharmaceuticals
ENTA
$377M
| $5.3M | 0.05% |
85,787
+14,413
| +20% | +$894K |
|
359
Talos Energy
TALO
$2.39B
| $5.3M | 0.05% |
175,741
+45,994
| +35% | +$1.07M |
|
360
Boston Properties
BXP
$11.1B
| $5.28M | 0.05% |
38,284
+7,634
| +25% | +$1.03M |
|
361
Oracle
ORCL
$344B
| $5.22M | 0.05% |
98,616
+43,436
| +79% | +$2.39M |
|
|
CSR
362
Centerspace
CSR
$943M
| $5.21M | 0.05% |
71,894
+39,053
| +119% | +$2.92M |
|
363
SPS Commerce
SPSC
$2.37B
| $5.21M | 0.05% |
93,930
-16,252
| -15% | -$864K |
|
364
Rayonier
RYN
$6.56B
| $5.2M | 0.05% |
174,820
-78,324
| -31% | -$2.13M |
|
|
GTS
365
DELISTED
Triple-S Management Corporation
GTS
| $5.19M | 0.05% |
280,934
+118,594
| +73% | +$2.02M |
|
366
Employers Holdings
EIG
$911M
| $5.19M | 0.05% |
124,250
+21,424
| +21% | +$909K |
|
367
TriCo Bancshares
TCBK
$1.85B
| $5.15M | 0.05% |
126,144
+6,319
| +5% | +$241K |
|
368
Evercore
EVR
$13B
| $5.13M | 0.05% |
68,558
-3,743
| -5% | -$285K |
|
369
Ionis Pharmaceuticals
IONS
$9.32B
| $5.12M | 0.05% |
84,724
-72,116
| -46% | -$4.3M |
|
|
RST
370
DELISTED
ROSETTA STONE INC
RST
| $5.11M | 0.05% |
281,828
+98,821
| +54% | +$1.68M |
|
|
FBM
371
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $5.11M | 0.05% |
263,937
+20,344
| +8% | +$390K |
|
372
iShares Russell 2000 Value ETF
IWN
$14.4B
| $5.05M | 0.05% |
+39,317
| New | +$4.86M |
|
|
TBRG
373
DELISTED
TruBridge
TBRG
| $5.05M | 0.05% |
191,259
+31,928
| +20% | +$797K |
|
374
Dow Inc
DOW
$20.9B
| $5.04M | 0.05% |
+92,031
| New | +$4.75M |
|
375
MYR Group
MYRG
$5.6B
| $5.03M | 0.05% |
154,306
+25,590
| +20% | +$845K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.